[1]Hernandez NM,Petis SM,Hanssen AD,et al.Infection after unicompartmental knee arthroplasty:A high risk of subsequent complications[J].Clin Orthop Relat Res,2019,477(1):70-77.
[2]Tay ML,McGlashan SR,Monk AP,et al.Revision indications for medial unicompartmental knee arthroplasty:A systematic review[J].Arch Orthop Trauma Surg,2021,142(2):301-314.
[3]Lee CS,Su EP,Cross MB,et al.Unicompartmental knee arthroplasty is associated with a lower rate of periprosthetic joint infection compared to total knee arthroplasty[J].Arthroplast Today,2021(10):117-122.
[4]Boyer B,Cazorla C.Methods and probability of success after early revision of prosthetic joint infections with debridement,antibiotics and implant retention[J].Orthop Traumatol Surg Res,2021,107(1 suppl):102774.
[5]Chang MJ,Lee SA,Kang SB,et al.A retrospective comparative study of infection control rate and clinical outcome between open debridement using antibiotic-impregnated cement beads and a two-stage revision in acute periprosthetic knee joint infection[J].Medicine(Baltimore),2020,99(4):e18891.
[6]Chalmers BP,Kapadia M,Chiu YF,et al.Treatment and outcome of periprosthetic joint infection in unicompartmental knee arthroplasty[J].J Arthroplasty,2020,35(7):1917-1923.
[7]Barbera JP,Xiao RC,Williams CS,et al.Treatment patterns and failure rates associated with prosthetic joint infection in unicompartmental knee arthroplasty:A systematic review[J].J Orthop,2022(34):288-294.
[8]Silva V,Almeida L,Gaio V,et al.Biofilm formation of multidrug-resistant mrsa strains isolated from different types of human infections[J].Pathogens,2021,10(8):970.
[9]Kelly JP,Bae AS,Taunton J,et al.Superficial surgical site infections in primary total joint arthroplasty:A retrospective analysis of topical anti-biofilm therapy[J].Cureus,2023,15(5):e39490.
[10]Prinz J,Wink M,Neuhaus S,et al.Effective biofilm eradication on Orthopaedic implants with methylene blue based antimicrobial photodynamic therapy in vitro[J].Antibiotics(Basel),2023,12(1):118.
[11]Kunutsor SK,Beswick AD,Whitehouse MR,et al.Debridement,antibiotics and implant retention for periprosthetic joint infections:A systematic review and meta-analysis of treatment outcomes[J].J Infect,2018,77(6):479-488.
[12]de Lachica JCV,Reyes SSS,Urena JAP,et al.Decrease in acute periprosthetic joint infections incidence with vancomycin-loaded calcium sulfate beads in patients with non-modifiable risk factors:A randomized clinical trial[J].J isakos,2022,7(6):201-205.
[13]Knecht CS,Moley JP,McGrath MS,et al.Antibiotic loaded calcium sulfate bead and pulse lavage eradicates biofilms on metal implant materials in vitro[J].J Orthop Res,2018,36(9):2349-2354.
[14]He JW,Wang J,Cao L,et al.Serum and Synovial vancomycin concentrations in patients with prosthetic joint infection after intra-articular infusion[J].Eur J Drug Metab Pharmacokinet,2021,46(5):637-643.
[15]唐淼,汤瑞新,周烨,等.利福平联合用药结合保留假体清创术治疗人工关节初期感染[J].实用骨科杂志,2017,23(7):593-596.
[16]Rottier W,Seidelman J,Wouthuyzen-Bakker M.Antimicrobial treatment of patients with a periprosthetic joint infection:Basic principles[J].Arthroplasty,2023,5(1):10.
[17]穆文博,曹力.保留假体清创术在治疗人工关节置换术后假体周围感染的研究进展[J].中山大学学报(医学科学版),2023,44(2):181-187.
[18]Vaz K,Scarborough M,Bottomley N,et al.Debridement,antibiotics and implant retention(DAIR)for the management of knee prosthetic joint infection[J].Knee,2020,27(6):2013-2015.